前沿生物与AFFiRiS宣布就靶向PCSK9的高胆固醇血症治疗药物AFFITOPE®AT04达成大中华区许可协议
December 22, 2021 04:00 ET
|
AFFiRiS AG
前沿生物获得在大中华区开发与商业化AFFITOPE®AT04的独家权利合作旨在加快AFFITOPE®AT04主动免疫疗法作为同类首创新药的全球开发进程，推动其在大中华区的临床开发和生产落地 中国南京和奥地利维也纳, Dec. 22, 2021 (GLOBE NEWSWIRE) --...
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
December 22, 2021 04:00 ET
|
AFFiRiS AG
Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater China Collaboration accelerates the global development of AFFiRiS potential first-in-class...
CVRx to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 21, 2021 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Dec. 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
Eko Named to the 2021 CB Insights Digital Health 150 List – Most Innovative Digital Health Startups
December 16, 2021 08:00 ET
|
Eko
OAKLAND, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Eko, a cardiopulmonary digital health company, has been named to the 2021 CB Insights Digital Health 150 list. The third annual ranking honors 150...
Radiofrequency Ablation Devices Market Size Worth $7,711.72 Million, Globally, by 2027 at 11.5% CAGR - Exclusive Report by The Insight Partners
December 16, 2021 07:41 ET
|
The Insight Partners
New York, Dec. 16, 2021 (GLOBE NEWSWIRE) -- According to the new market research report "Radiofrequency Ablation Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product...
Philips introduces fully integrated echocardiography experience, bringing together new transducer technology, AI-driven automated measurements and remote access at EuroEcho 2021
December 09, 2021 04:00 ET
|
Royal Philips
December 9, 2021 Philips’ next-generation nSIGHT Plus imaging architecture and new X5-1c Transthoracic Transducer drive breakthrough cardiac imaging performance Debut of AI-enhanced Auto Measure...
CVRx to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 16, 2021 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Nov. 16, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally...
Clinical Trial Market Size & Share 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
November 09, 2021 06:00 ET
|
Graphical Research
Pune, India, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The global clinical trial market size is estimated to rise exponentially during the forecast period, as the need for advanced vaccines and drugs to...
CVRx Reports Third Quarter 2021 Financial and Operating Results
November 04, 2021 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Nov. 04, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and...
Retrospective Analysis Using the VoluMetrix NIVA|HF Investigational Algorithm to Assess Patients With Heart Failure Predicts Hospitalization
November 04, 2021 09:00 ET
|
VoluMetrix
NASHVILLE, Tenn., Nov. 04, 2021 (GLOBE NEWSWIRE) -- VoluMetrix, a Nashville-based biotech startup dedicated to creating a new wave of solutions for vital monitoring to enhance well-being, today...